Guardant Health (NASDAQ:GH) will report Q2 2026 results July 30 after the close and host a 1:30 p.m. PT / 4:30 p.m. ET earnings call, as recent analyst optimism—Evercore and BofA raising price targets to $200 and $190—underscores growing investor interest ahead of the update.
Previous Week Recap
- Guardant Health Q2 2026 Results Date: Guardant Health (GH) will report Q2 2026 results July 30 after market close and host a webcast/earnings call at 1:30 p.m. PT / 4:30 p.m. ET for investors and traders.
- Analysts Boost Guardant Price Targets: Analysts lifted Guardant Health (GH) price targets: Evercore raised target to $200 from $160; Bank of America lifted target to $190 from $135. Both kept their positive ratings.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.